Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 31 of 31 entries
Sorted by: Best Match Show Resources per page
Ferromagnetic properties of the Zn-Mn-O system.

Journal of physics. Condensed matter : an Institute of Physics journal

Babić-Stojić B, Milivojević D, Blanuša J, Spasojević V, Bibić N, Simonović B, Arandelović D.
PMID: 21694308
J Phys Condens Matter. 2008 Jun 11;20(23):235217. doi: 10.1088/0953-8984/20/23/235217. Epub 2008 May 06.

Polycrystalline Zn-Mn-O samples with nominal manganese concentration x = 0.01 and 0.10 were synthesized by a solid state reaction route using (ZnC(2)O(4)·2H(2)O)(1-x) and (MnC(2)O(4)·2H(2)O)(x). Thermal treatment of the samples was carried out in air at temperatures of 673, 773...

Cite
Babić-Stojić B, Milivojević D, Blanuša J, et al. Ferromagnetic properties of the Zn-Mn-O system. J Phys Condens Matter. 2008;20(23):235217doi: 10.1088/0953-8984/20/23/235217.
Babić-Stojić, B., Milivojević, D., Blanuša, J., Spasojević, V., Bibić, N., Simonović, B., & Arandelović, D. (2008). Ferromagnetic properties of the Zn-Mn-O system. Journal of physics. Condensed matter : an Institute of Physics journal, 20(23), 235217. https://doi.org/10.1088/0953-8984/20/23/235217
Babić-Stojić, B, et al. "Ferromagnetic properties of the Zn-Mn-O system." Journal of physics. Condensed matter : an Institute of Physics journal vol. 20,23 (2008): 235217. doi: https://doi.org/10.1088/0953-8984/20/23/235217
Babić-Stojić B, Milivojević D, Blanuša J, Spasojević V, Bibić N, Simonović B, Arandelović D. Ferromagnetic properties of the Zn-Mn-O system. J Phys Condens Matter. 2008 Jun 11;20(23):235217. doi: 10.1088/0953-8984/20/23/235217. Epub 2008 May 06. PMID: 21694308.
Copy Download .nbib Format: NLM
Synthesis, Characterization and Biological Studies of Organoselenium trans-Palladium(II) Complexes.

Medicinal chemistry (Shariqah (United Arab Emirates))

Raković I, Bogojeski J, Mladenović K, Petrović A, Divac V, Mihailović K, Jovicić BP, Kostić M, Canović P, Milivojević N, Zivanović M, Radojević I.
PMID: 32998677
Med Chem. 2021;17(9):1007-1022. doi: 10.2174/1573406416666200930112442.

BACKGROUND: Over the years, transition metal complexes have exhibited significant antimicrobial and antitumor activity. It all started with cisplatin discovery, but due to the large number of side effects it shows, there is a growing need to find a...

Cite
Raković I, Bogojeski J, Mladenović K, et al. Synthesis, Characterization and Biological Studies of Organoselenium trans-Palladium(II) Complexes. Med Chem. 2021;17(9):1007-1022doi: 10.2174/1573406416666200930112442.
Raković, I., Bogojeski, J., Mladenović, K., Petrović, A., Divac, V., Mihailović, K., Jovicić, B. P., Kostić, M., Canović, P., Milivojević, N., Zivanović, M., & Radojević, I. (2021). Synthesis, Characterization and Biological Studies of Organoselenium trans-Palladium(II) Complexes. Medicinal chemistry (Shariqah (United Arab Emirates)), 17(9), 1007-1022. https://doi.org/10.2174/1573406416666200930112442
Raković, Ivana, et al. "Synthesis, Characterization and Biological Studies of Organoselenium trans-Palladium(II) Complexes." Medicinal chemistry (Shariqah (United Arab Emirates)) vol. 17,9 (2021): 1007-1022. doi: https://doi.org/10.2174/1573406416666200930112442
Raković I, Bogojeski J, Mladenović K, Petrović A, Divac V, Mihailović K, Jovicić BP, Kostić M, Canović P, Milivojević N, Zivanović M, Radojević I. Synthesis, Characterization and Biological Studies of Organoselenium trans-Palladium(II) Complexes. Med Chem. 2021;17(9):1007-1022. doi: 10.2174/1573406416666200930112442. PMID: 32998677.
Copy Download .nbib Format: NLM
Dyspepsia Challenge in Primary Care Gastroenterology.

Digestive diseases (Basel, Switzerland)

Milivojevic V, Rankovic I, Krstic MN, Milosavljevic T.
PMID: 34126614
Dig Dis. 2021 Jun 14; doi: 10.1159/000517668. Epub 2021 Jun 14.

BACKGROUND: The purpose of this review is to take a deep dive into general problems and challenges of diagnosis and treatment of patients with symptoms of dyspepsia in primary care practice.SUMMARY: Primary care physicians become acquainted with a broad...

Cite
Milivojevic V, Rankovic I, Krstic MN, et al. Dyspepsia Challenge in Primary Care Gastroenterology. Dig Dis. 2021;doi: 10.1159/000517668.
Milivojevic, V., Rankovic, I., Krstic, M. N., & Milosavljevic, T. (2021). Dyspepsia Challenge in Primary Care Gastroenterology. Digestive diseases (Basel, Switzerland), . https://doi.org/10.1159/000517668
Milivojevic, Vladimir, et al. "Dyspepsia Challenge in Primary Care Gastroenterology." Digestive diseases (Basel, Switzerland) vol. (2021). doi: https://doi.org/10.1159/000517668
Milivojevic V, Rankovic I, Krstic MN, Milosavljevic T. Dyspepsia Challenge in Primary Care Gastroenterology. Dig Dis. 2021 Jun 14; doi: 10.1159/000517668. Epub 2021 Jun 14. PMID: 34126614.
Copy Download .nbib Format: NLM
Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study.

Journal of cardiovascular development and disease

Stojanovic M, Raskovic S, Milivojevic V, Miskovic R, Soldatovic I, Stankovic S, Rankovic I, Stankovic Stanojevic M, Dragasevic S, Krstic M, Diamantopoulos AP.
PMID: 34940542
J Cardiovasc Dev Dis. 2021 Dec 14;8(12). doi: 10.3390/jcdd8120187.

Takayasu Arteritis (TA) is characterized by granulomatous panarteritis, vessel wall fibrosis, and irreversible vascular impairment. The aim of this study is to explore the usefulness of the Enhanced Liver Fibrosis score (ELF), procollagen-III aminoterminal propeptide (PIIINP), tissue inhibitor of...

Cite
Stojanovic M, Raskovic S, Milivojevic V, et al. Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study. J Cardiovasc Dev Dis. 2021;8(12)doi: 10.3390/jcdd8120187.
Stojanovic, M., Raskovic, S., Milivojevic, V., Miskovic, R., Soldatovic, I., Stankovic, S., Rankovic, I., Stankovic Stanojevic, M., Dragasevic, S., Krstic, M., & Diamantopoulos, A. P. (2021). Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study. Journal of cardiovascular development and disease, 8(12), . https://doi.org/10.3390/jcdd8120187
Stojanovic, Maja, et al. "Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study." Journal of cardiovascular development and disease vol. 8,12 (2021). doi: https://doi.org/10.3390/jcdd8120187
Stojanovic M, Raskovic S, Milivojevic V, Miskovic R, Soldatovic I, Stankovic S, Rankovic I, Stankovic Stanojevic M, Dragasevic S, Krstic M, Diamantopoulos AP. Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study. J Cardiovasc Dev Dis. 2021 Dec 14;8(12). doi: 10.3390/jcdd8120187. PMID: 34940542.
Copy Download .nbib Format: NLM
Targeting Stress Pathophysiology to Improve Alcoholism Relapse Outcomes.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Milivojevic V, Sinha R.
PMID: 27713485
Neuropsychopharmacology. 2017 Apr;42(5):987-988. doi: 10.1038/npp.2016.234. Epub 2016 Oct 07.

No abstract available.

Cite
Milivojevic V, Sinha R. Targeting Stress Pathophysiology to Improve Alcoholism Relapse Outcomes. Neuropsychopharmacology. 2016;42(5):987-988doi: 10.1038/npp.2016.234.
Milivojevic, V., & Sinha, R. (2017). Targeting Stress Pathophysiology to Improve Alcoholism Relapse Outcomes. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 42(5), 987-988. https://doi.org/10.1038/npp.2016.234
Milivojevic, Verica, and Sinha, Rajita. "Targeting Stress Pathophysiology to Improve Alcoholism Relapse Outcomes." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 42,5 (2017): 987-988. doi: https://doi.org/10.1038/npp.2016.234
Milivojevic V, Sinha R. Targeting Stress Pathophysiology to Improve Alcoholism Relapse Outcomes. Neuropsychopharmacology. 2017 Apr;42(5):987-988. doi: 10.1038/npp.2016.234. Epub 2016 Oct 07. PMID: 27713485; PMCID: PMC5506789.
Copy Download .nbib Format: NLM
Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey.

Journal of Crohn's & colitis

Ellul P, Revés J, Abreu B, Chaparro M, Gisbert JP, Allocca M, Fiorino G, Barberio B, Zingone F, Pisani A, Cassar D, Michalopoulos G, Mantzaris G, Koutroubakis I, Karmiris K, Katsanos K, Ďuricova D, Burisch J, Madsen GR, Maaser C, Arebi N, Orfanoudaki E, Milivojevic V, Buisson A, Avedano L, Leone S, Torres J.
PMID: 35037033
J Crohns Colitis. 2022 Jan 17; doi: 10.1093/ecco-jcc/jjac010. Epub 2022 Jan 17.

INTRODUCTION: Anti-SARS-CoV-2 vaccines clinical trials did not include patients with immune-mediated conditions such as inflammatory bowel disease (IBD). We aimed to describe the implementation of anti-SARS-CoV-2 vaccination among IBD patients, patients' concerns and side-effect profile of the anti-SARS-CoV-2 vaccines...

Cite
Ellul P, Revés J, Abreu B, et al. Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey. J Crohns Colitis. 2022;doi: 10.1093/ecco-jcc/jjac010.
Ellul, P., Revés, J., Abreu, B., Chaparro, M., Gisbert, J. P., Allocca, M., Fiorino, G., Barberio, B., Zingone, F., Pisani, A., Cassar, D., Michalopoulos, G., Mantzaris, G., Koutroubakis, I., Karmiris, K., Katsanos, K., Ďuricova, D., Burisch, J., Madsen, G. R., Maaser, C., Arebi, N., Orfanoudaki, E., Milivojevic, V., Buisson, A., Avedano, L., Leone, S., & Torres, J. (2022). Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjac010
Ellul, Pierre, et al. "Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey." Journal of Crohn's & colitis vol. (2022). doi: https://doi.org/10.1093/ecco-jcc/jjac010
Ellul P, Revés J, Abreu B, Chaparro M, Gisbert JP, Allocca M, Fiorino G, Barberio B, Zingone F, Pisani A, Cassar D, Michalopoulos G, Mantzaris G, Koutroubakis I, Karmiris K, Katsanos K, Ďuricova D, Burisch J, Madsen GR, Maaser C, Arebi N, Orfanoudaki E, Milivojevic V, Buisson A, Avedano L, Leone S, Torres J. Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey. J Crohns Colitis. 2022 Jan 17; doi: 10.1093/ecco-jcc/jjac010. Epub 2022 Jan 17. PMID: 35037033.
Copy Download .nbib Format: NLM
Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: .

Oxidative medicine and cellular longevity

Sherikar A, Siddique MUM, More M, Goyal SN, Milivojevic M, Alkahtani S, Alarifi S, Hasnain MS, Nayak AK.
PMID: 34804361
Oxid Med Cell Longev. 2021 Nov 10;2021:1818538. doi: 10.1155/2021/1818538. eCollection 2021.

Solubility of phytochemicals is a major concern for drug delivery, permeability, and their biological response. However, advancements in the novel formulation technologies have been helping to overcome these challenges. The applications of these newer technologies are easy for commercialization...

Cite
Sherikar A, Siddique MUM, More M, et al. Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: . Oxid Med Cell Longev. 2021;2021:1818538doi: 10.1155/2021/1818538.
Sherikar, A., Siddique, M. U. M., More, M., Goyal, S. N., Milivojevic, M., Alkahtani, S., Alarifi, S., Hasnain, M. S., & Nayak, A. K. (2021). Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: . Oxidative medicine and cellular longevity, 20211818538. https://doi.org/10.1155/2021/1818538
Sherikar, Abdulla, et al. "Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: ." Oxidative medicine and cellular longevity vol. 2021 (2021): 1818538. doi: https://doi.org/10.1155/2021/1818538
Sherikar A, Siddique MUM, More M, Goyal SN, Milivojevic M, Alkahtani S, Alarifi S, Hasnain MS, Nayak AK. Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: . Oxid Med Cell Longev. 2021 Nov 10;2021:1818538. doi: 10.1155/2021/1818538. eCollection 2021. PMID: 34804361; PMCID: PMC8598371.
Copy Download .nbib Format: NLM
Showing 25 to 31 of 31 entries